Cedilla Therapeutics
Latest round
- Series B
Last raised
- Oct 2021
Total raised
- $111M
Investors
- 9
About Cedilla Therapeutics
Founded in 2018 and based in Massachusetts, US, Cedilla Therapeutics, Inc. operates as a biotechnology company that develops small-molecule therapeutics that target cancer drivers and treat life-threatening diseases. It focuses on destabilizing oncoprotein targets that include direct ligand-induced degradation, upstream regulators, protein orphaning, and proteome susceptibility mapping.
Who invested in Cedilla Therapeutics
9 investors across 3 rounds
See all investors in Cedilla Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Cedilla Therapeutics
Who invested in Cedilla Therapeutics?
Cedilla Therapeutics has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Cedilla Therapeutics raised?
Cedilla Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Cedilla Therapeutics last raise money?
Cedilla Therapeutics's most recent round on record is a Series B, in Oct 2021.
What does Cedilla Therapeutics do?
Founded in 2018 and based in Massachusetts, US, Cedilla Therapeutics, Inc.
Where is Cedilla Therapeutics headquartered?
Cedilla Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Cedilla Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Cedilla Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Cedilla Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.